Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 20,709,044 $ 24,907,963
Accounts receivable, net 2,352,463 2,291,533
Other receivables   526,070
Prepaid expenses and other current assets 411,904 495,178
Total Current Assets 23,473,411 28,220,744
Intangible assets, net 2,789,625 2,946,610
Goodwill 463,000 463,000
Property and equipment, net 47,040 44,756
Deferred offering costs 10,000 10,000
Total Assets 26,783,076 31,685,110
Current Liabilities:    
Accounts payable - suppliers 2,474,570 1,844,544
Accounts payable - trade 1,050,395 659,362
Accrued expenses and other current liabilities 851,800 2,493,287
Deferred revenue 26,719 395,914
Notes payable 42,066 151,336
Total Current Liabilities 4,445,550 5,544,443
Contingent consideration 23,378 613,000
Notes payable, non-current portion 77,407 77,407
Total Liabilities 4,546,335 6,234,850
Commitments and contingencies (Note 5)
Stockholders' Equity :    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of March 31, 2022 and December 31, 2021
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,303,743 and 14,253,948 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 143 143
Additional paid-in capital 52,444,880 52,030,907
Accumulated deficit (30,208,282) (26,580,790)
Total Stockholders' Equity 22,236,741 25,450,260
Total Liabilities and Stockholders' Equity $ 26,783,076 $ 31,685,110